Shanghai OPM Bioengineering Co., Ltd announced a private placement for the gross proceeds of CNY 321,430,000 on September 23, 2022. The transaction includes participation from Shanghai OPM Biosciences Co., Ltd. Out of the total amount received, CNY 30,000,000 will form part of registered capital and rest will be received as capital reserve. The transaction has been approved in the 11th Meeting of the Company’s 1st Directorate and the 7th Meeting of the 1st Supervisory Board.